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LETTER TO THE EDITOR
Human cancer DNA fingerprint analysis
Sir - The use of DNA fingerprinting by Thein et al. (1987)
to detect somatic changes in human cancer DNA provides a
novel strategy with potential application to the study of
genomic rearrangement, clonality and tumour evolution. The
selection of constitutional DNA unrelated to the malignant
clone is clearly of critical importance, and in this respect
some of their data may be questioned. Eight of the 35
patients reported had myelodysplastic syndromes (MDS) and
in these Epstein-Barr virus (EBV) transformed B cells were
used as a source of constitutional DNA. Clonality studies
utilising G6PD isoenzyme expression, however, indicate
that B lymphocytes may be clonally derived in MDS (Prchal
et al., 1978; Raskind et al., 1984). The occurrence of
lymphoid and biphenotypic transformation (Layton & Mufti,
1986), defects of B lymphocyte, T lymphocyte and NK cell
function (Jacobs, 1985) and coexistence with lympho-
proliferative disorders (Copplestone et al., 1986) provides
further evidence consistent with the view that a progenitor
bipotent for lymphoid and myeloid differentiation is
involved in MDS. Thus the choice of EBV transformed B
cells as a source of constitutional DNA in patients with
MDS seems inappropriate and might perhaps explain the
absence of somatic alteration within this sub-group of
patients. An alternative source of constitutional DNA, for
instance, hair roots may be more appropriate in cases of
haematological neoplasia in which the stem cell origin is
imprecisely defined.
Yours etc.,
D.M. Layton and G.J. Mufti
Department of Haematology
King's College School of Medicine and Dentistry
Denmark Hill
London SE5 8RX, UK.
References
COPPLESTONE, J.A., MUFTI, G.J.M., HAMBLIN, T.J. & OSCIER, D.G.
(1986). Immunological abnormalities in myelodysplastic
syndromes. II. Coexistent lymphoid or plasma cell neoplasms: A
report of 20 cases unrelated to chemotherapy. Br. J. Haematol.,
63, 149.
JACOBS, A. (1985). Myelodysplastic syndromes: Pathogenesis,
functional abnormalities and clinical implications. J. Clin.
Pathol., 38, 1201.
LAYTON, D.M. & MUFTI, G.J.M. (1986). Myelodysplastic syndromes:
Their history, evolution and relation to acute myeloid leukaemia.
Blut, 53, 423.
PRCHAL, J.T., THROCKMORTON, D.W., CARROLL, A.J., FUSON,
E.W., GAMS, R.A. & PRCHAL, J.F. (1978). A common progenitor
for human myeloid and lymphoid cells. Nature, 274, 590.
RASKIND, W.H., TIRUMALI, N., JACOBSON, R., SINGER, J. &
FIALKOW, P.J. (1984). Evidence for a multistep pathogenesis of a
myelodysplastic syndrome. Blood, 63, 1318.
THEIN, S.L., JEFFREYS, A.J., GOOI, M.C. & 5 others (1987).
Detection of somatic changes in human cancer DNA by DNA
fingerprint analysis. Br. J. Cancer, 55, 353.
Drs Thein & Wainscoat reply:
Sir - Doctors Layton and Mufti raise the important question
of the source of constitutional DNA for the DNA
fingerprinting studies of myelodysplasia (MDS). We accept
that the use of EBV-transformed lymphocytes as a source of
constitutional DNA for this category of patients is not ideal.
Nevertheless, very few cases of MDS have been shown to
have B cell involvement as part of the malignant clone. We
are continuing the analysis of DNA fingerprints in the
reported patients using different minisatellite probes. One of
the original MDS patients clearly shows a different pattern
in the tumour DNA as compared to the EBV-transformed
lymphocyte DNA with probe 33.6. The advantage of using
EBV-transformed lymphocyte DNA is, of course, that the
supply of DNA is unlimited. However, we have also been
concerned by the general problem of a source of
constitutional DNA for studies in leukaemia and have
recently shown that DNA extracted from hair roots is truly
constitutional (Pilkington et al., 1987). The total amount of
DNA obtained from this source, however, is small and is of
the order of 5 pg. The solution to this problem is to compare
the DNA fingerprints from tumour tissues, EBV-transformed
lymphocytes and hair root follicles using several different
minisatellite probes. This study is now in progress.
Yours etc.,
S.L. Thein
Nuffield Department of Medicine
John Radcliffe Hospital
Headington, Oxford OX3 9DU.
J.S. Wainscoat
Department of Haematology
John Radcliffe Hospital
Headington, Oxford OX3 9DU, UK.
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